Fortis Healthcare Ltd. · NSE:FORTIS
Fortis Healthcare — Q1 FY27 Earnings Presentation
27 slides from Fortis Healthcare's earnings presentation, Aug 6, 2026
Slide 1: Fortis Healthcare Limited Earnings Presentation – Q1 FY27
FORTIS HEALTHCARE LIMITED EARNINGS PRESENTATION – Q1 FY27 August 06, 2026 1
Slide 2: Disclaimer
DISCLAIMER This presentation may not be copied, published, distributed or transmitted. The presentation has been prepared solely by the company. Any reference in this presentation to “Fortis Healthcare Limited” shall mean, collectively, the Company and its subsidiaries. This presentation has been pr
Slide 3: About Fortis Healthcare
About Fortis Healthcare National Capital Region ➢ FMRI, Gurugram ➢ FEHI, New Delhi 36 Healthcare Facilities ➢ Shalimar Bagh 2,191 ➢ Noida Himachal Pradesh ➢ Vasant Kunj (O&M) ➢ Kangra 81 ➢ Faridabad 6,150+ Operational Beds^ ➢ Manesar, Gurugram Punjab ➢ La Femme GK ➢ Mohali ➢ Def Col ➢ Ludhiana 989 ➢
Slide 4: Agenda
AGENDA 1. Performance Highlights • Earnings and Financial Summary – Q1FY27 2. Performance Review - Hospital Business 3. Performance Review - Diagnostics Business 4. Clinical Excellence at Fortis 5. Appendix 4
Slide 5: Q1FY27 Performance Highlights
Q1FY27 PERFORMANCE HIGHLIGHTS 5
Slide 6: Q1FY27 Snapshot
Q1FY27 SNAPSHOT Consolidated Revenue Consolidated Op EBITDA1 Consolidated PBT2 2,545 Crores 568 Crores 354 Crores (22.3% Margin) 17.5% 15.8% 4.6% Consolidated PAT2 Net Debt / (Cash)4 Net Debt to EBITDA3,4 263 Crores 2,233 Crores 1.01x vs 0.92x 3.6% 1. Excluding ESOP expenses of ~INR 31 Cr. 2. Exclud
Slide 7: Q1FY27 Snapshot
Q1FY27 SNAPSHOT ➢ Hospital business revenues grew 19% to INR 2,187 Cr versus INR 1,838 Cr in Q1FY26 ➢ Hospital Business Operating EBITDA* stood at INR 471 Cr, up 15.9%; while operating margin was at 21.5% versus 22.1% in Q1FY26. On a like-for-like basis, excluding the impact of the newly acquired /
Slide 8: Consolidated Earnings Summary – Q1FY27
CONSOLIDATED EARNINGS SUMMARY – Q1FY27 All figures in INR Cr Revenue Op EBITDA & Margin 2,545 2,365 568 2,167 531 22.3% 491 22.5% 22.6% Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 ^ Up 17.5% Up 15.8% PBT before Exceptional Items PAT* 354 284 254 263 338 337 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Up
Slide 9: Consolidated Earnings Summary
CONSOLIDATED EARNINGS SUMMARY All figures in INR Cr Consolidated Revenue 2,545 2,331 2,365 2,265 2,167 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27 Op EBITDA Margin Op EBITDA PBT (before Exceptional items) 23.9% 22.3% 22.3% 22.5% 22.6% 568 556 531 491 505 402 338 337 354 312 Q1FY26 Q2FY26 Q3FY26 Q4FY26 Q1FY27
Slide 10: Hospital Business Highlights
Q1FY27 HOSPITAL BUSINESS HIGHLIGHTS Key Performance Indicators Overall Occupancy • Occupancy was at 69%, similar to Q1FY26. Occupied beds 69% 68% 69% increased to 3,418 compared to 2,928 in Q1FY26, a growth of 16.7%. • Revenue from focus specialties comprising Oncology, Neurosciences, Cardiac Scienc
Slide 11: Diagnostic Business Highlights
Q1FY27 DIAGNOSTIC BUSINESS HIGHLIGHTS • Agilus reported gross revenue of INR 407 Cr in Q1FY27 as compared to INR 369 Cr in Q1FY26, a growth of 10%. • Operating EBITDA stood at INR 97 Cr* in Q1FY27 versus INR 85 Cr in Q1FY26. • Operating EBITDA Margin (basis gross revenues) stood at 23.9%* versus 23.
Slide 12: Operating Performance – Hospital Business
OPERATING PERFORMANCE HOSPITAL BUSINESS Hospital Business Particulars (INR Cr) Q1FY26 Q4FY26 Q1FY27 Operating Revenue 1,838 2,023 2,187 Revenue Growth vs LY 18.6% 19.0% 19.0% Reported EBITDA 415 446 451 EBITDA growth vs LY 40.5% 16.1% 8.8% Margin 22.6% 22.0% 20.6% Less: Other Income^ 9 (0) 11 Add: E
Slide 13: Operating Performance – Diagnostic Business
OPERATING PERFORMANCE DIAGNOSTIC BUSINESS Diagnostic Business Particulars (INR Cr) Q1FY26 Q4FY26 Q1FY27 Operating Revenue 369 387 407 Revenue Growth vs LY 7.4% 11.1% 10.2% Reported EBITDA 91 97 107 EBITDA growth vs LY 51.4% 35.7% 16.7% Margin 24.7% 24.9% 26.2% Less: Other Income incl FX 7 11 10 Add:
Slide 14: Balance Sheet (Consolidated)
BALANCE SHEET (CONSOLIDATED) June 30, 2026 Balance Sheet (INR Cr) Jun 30, 2025 Mar 31, 2026 Jun 30, 2026 Shareholder’s Equity 9,435 10,168 10,472 Debt 2,355 2,872 2,580 Lease Liabilities (Ind AS 116)* 274 600 616 Total Capital Employed 12,064 13,640 13,667 Net Fixed Assets (including intangibles & C
Slide 15: Performance Review – Hospitals Business
PERFORMANCE REVIEW HOSPITALS BUSINESS 15
Slide 16: Specialty Mix
SPECIALTY MIX Q1FY26 Q1FY27 Other Operating Other Operating Revenue, 1.9% Revenue, 1.7% Cardiac, Cardiac, OPD, 13.9% OPD, 14.4% 16.9% 16.6% Other IPD, Ortho, 9.9% Other IPD, Ortho, 10.3% 15.4% 16.1% Renal, 6.9% Renal, 7.3% Gynae, 3.1% Gynae, 3.1% Pulmo, 2.5% Neuro, 8.1% Neuro, 8.6% Pulmo, 2.8% Onco,
Slide 17: Payor Mix
PAYOR MIX Q1FY26 Q1FY27 ESI, 0.1% TPAs, 37.1% TPAs, 37.2% Cash : Cash : Domestic, Domestic, 33.6% 33.3% Pvt Corps, 1.0% Pvt Corps, International , International , 1.2% 7.5% 7.9% Govt & Govt & PSUs, PSUs, 8.4% ECHS, 7.1% 8.7% CGHS, 4.3% ECHS, 7.3% CGHS, 5.2% 17
Slide 18: Hospital Margin Matrix
HOSPITAL MARGIN MATRIX EBITDA* No of Facilities Revenue Contribution Operational beds ARPOB (INR Cr) Occupancy >20% 14 70.3% 3,212 2.71 74% Q1FY27 15% - 20% 4 18.0% 809 3.19 66% 10% - 15% 2 4.1% 331 2.08 54% <10% 4^ 6.4% 588 1.93 54% * Operating EBITDA margin excludes ESOP expenses EBITDA No of Faci
Slide 19: Performance Review – Diagnostics Business
PERFORMANCE REVIEW DIAGNOSTICS BUSINESS 19
Slide 20: Diagnostics Business
DIAGNOSTICS BUSINESS • During Q1FY27, Agilus conducted 10.46 Mn tests, versus 10.13 Mn in Q1FY26. • Agilus added 200+ Customer touchpoints* to its network in Q1FY27. • Agilus’ B2C: B2B revenue mix stood at 53:47 in the quarter vs 51:49 in Q1FY26. • Operating EBITDA stood at INR 97 Cr ^ in Q1FY27 ver
Slide 21: Quarterly Revenue Mix
QUARTERLY REVENUE MIX Geographic mix Product Mix Segment Mix International 4% Wellness 14% B2C, Q1FY27 North 53% South 31% 33% Routine B2B, 51% 47% Specialised 35% East 13% West 19% International 4% Wellness 12% B2C, North 51% Q1FY26 South 31% 31% Routine B2B, Specialised 54% 49% 34% East West 13% 2
Slide 22: Quarterly Key Performance Metrics
QUARTERLY KEY PERFORMANCE METRICS Test (mn) Avg. Realization per test (INR) No of Patients (mn) Avg. Realization per patient (INR) 4.50 960 10.8 390 10.6 4.40 952 387 385 940 10.4 4.30 380 10.2 4.20 920 375 922 10 375 375 4.10 370 890 900 9.8 4.00 900 903 369 365 9.6 3.90 880 365 878 9.4 363 360 3.8
Slide 23: Clinical Excellence at Fortis
CLINICAL EXCELLENCE AT FORTIS KEY HIGHLIGHTS 23
Slide 24: Clinical Excellence & Medical Programs
CLINICAL EXCELLENCE & MEDICAL PROGRAMS Clinical Excellence Augmenting Medical Programs ➢ Fortis Escorts, Okhla Road, New Delhi, conducted ➢ Fortis Escorts, Okhla Road, New Delhi and Fortis a 10-hour surgery to remove a rare cancerous Escorts Hospital, Faridabad, inaugurated advanced tumour (abdomina
Slide 25: Appendix
| x la Z uu Oo. oO. <x
Slide 26: Group Consolidated P&L – Q1FY27
GROUP CONSOLIDATED P&L – Q1FY27 Particulars ( INR Cr) Q1FY26 Q4FY26 Q1FY27 Revenue from operations 2,166.7 2,364.7 2,545.0 Other income 15.4 4.4 14.5 Total income 2,182.1 2,369.1 2,559.5 Expenses 1,676.0 1,832.3 2,007.9 EBITDA* 506.1 536.7 551.6 Margin 23.4% 22.7% 21.7% Finance costs 69.6 84.3 80.4
Slide 27: Thank You
THANK YOU 27